Copernicus Therapeutics Incorporated
Registration country:United States
Developer of a non-viral delivery system for the non-toxic delivery of nucleic acid drugs.
Copernicus Therapeutics Inc., a biotechnology company, develops a non-viral delivery system for the non-toxic delivery of nucleic acid drugs in the United States. Its non-viral delivery system is suitable for the delivery of nucleic acid drugs that permits various therapies for human diseases. The company focuses on the development of therapies to treat diseases that have therapeutic options, including diseases causing blindness, airborne viral diseases, and diseases of the brain. Copernicus Therapeutics, Inc. was formerly known as Copernicus Gene Systems, Inc. and changed its name to Copernicus Therapeutics, Inc. in 1999. The company was founded in 1995 and is based in Cleveland, Ohio.